What does BroadOak Capital Partners invest in?
BroadOak Capital Partners invests most often at Venture and Growth (50% of the rounds on record), in sectors such as Courier Service, Delivery and Banking.

United States · Investor
Last cheque observed Oct 2026; 10 cheques on record.
Deploying nowNew fund $115M, May 2025VC firm
Follow BroadOak Capital Partners and see its new cheques in your feed.Start following
2 cheques in the last 12 months
Mostly Venture and Growth: 50% of its rounds
Sole investor in 2 rounds, median $2.5M
Filed 1 private fund offering with the SEC, the most recent in 2021-09From their own website
Every round we can evidence, newest first10 appearances
2 rounds
1 round
1 round
2 rounds
1 round
2 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration9 named
We also hold 20 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Funds on its Form ADV
8 private funds, $371M in gross assets · filed Mar 2024
Private equity 7Venture 1
From their own portfolio page (on their website)
A&G PharmaceuticalAlleviBioNex SolutionsCardeaEmpire GenomicsEpiCypherGenomenonHalo LabsHuman LongevityNaniteNoble Life SciencesOpentronsRoosterBiosizedSeqWellindee labsinsphero squarequartzyActive MotifAkron BioAlpha InnotechAnametAragenArgonaut Manufacturing ServicesAvidienAzure biosystemsBiologsizedBiomericaBiosynthBroadOak Precision cellCS GeneticsCayman ChemicalCodis Logo 1DANIDiagnostic BioSystemsDistributed BioEmVenioFINRAFlagship Resized Logo2Fluidic Sciences Logo 1GeminiBioGold Standard DiagnosticsGrantHBioHoneycombHorizon InfusionsHudson Lab AutomationIC BiomedicalIXRF SystemsInterpace BiosciencesKemp Proteins LOGO e1655757547862Kromatid newLabVoice Logo TransparentMicrosizeOligo Factory logo 1Orflo logo22222OriGenePAK BioSolutionsPBS BiotechPrognosPubgradeand 20 more
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as BroadOak Capital Partners. A count of rooms they were both in, not a relationship either has claimed.
The latest companies BroadOak Capital Partners put money into.
BroadOak Capital Partners invests most often at Venture and Growth (50% of the rounds on record), in sectors such as Courier Service, Delivery and Banking.
10 investments on record, 2 of them in the last 12 months. The most recent was in Oct 2026.
Its most recent investments on record: Opentrons Labworks Inc. (Series E, Oct 2026), Quartzy (Growth, Apr 2026) and PBS Biotech (Growth, Jan 2025).
The median round it joins is $23M.
Rarely, if at all: none of its 10 investments on record names it as the lead.
Most of the companies it backs are in the United States (100%).
Yes: it is actively investing, with 2 investments in the last 12 months.
Most often Avego Management (2 rounds together) and Research Corporation Technologies (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it